Christina Bender
About Christina Bender
Christina Bender is the Exploratory Biomarker Lead for WW Oncology Commercialization at Bristol-Myers Squibb and the Director of Global Oncology Diagnostic Commercial Strategy at Novartis. She has extensive experience in global oncology commercialization strategies and a strong background in molecular biology and business management.
Title
Christina Bender serves as the Exploratory Biomarker Lead for Worldwide Oncology Commercialization at Bristol-Myers Squibb in New Jersey, United States.
Current Roles at Bristol-Myers Squibb and Novartis
Christina Bender currently holds the position of Exploratory Biomarker Lead in Worldwide Oncology Commercialization at Bristol-Myers Squibb. Simultaneously, she works as the Director for Global Oncology, Diagnostic Commercial Strategy at Novartis, based in Basel, Basel-City, Switzerland.
Past Experience at Novartis
Christina Bender has extensive experience with Novartis, where she previously held key roles, including Associate Director of Global Hematology Diagnostic Marketing Strategy from 2011 to 2014 and Associate Director of Neuroscience and Oncology Business Analysis and Market Research from 2006 to 2011, both based in Basel, Basel-City, Switzerland.
Previous Positions at Eisai, Gyros Protein Technologies, and Molecular Devices
Christina worked at Eisai as a Senior Analyst in Marketing Research and Business Analysis from 2005 to 2006. Prior to that, she was the Genomics Key Account Manager at Gyros Protein Technologies AB from 2001 to 2005 in Uppsala, Sweden. Earlier in her career, she was a Genomics Sales Specialist at Molecular Devices from 1999 to 2001 in San Jose, California, United States.
Education and Expertise
Christina Bender boasts a strong educational background. She obtained her Bachelor of Science in Biological Science from the University of California, Los Angeles. She then pursued her Doctor of Philosophy in Molecular Biology and Biochemistry from the University of Southern California. Furthering her education, she studied at the University of London focusing on Molecular Biology and Biochemistry, and completed her Master of Business Administration in Marketing and Management from Rutgers University - Newark.